Target Price | $179.52 |
Price | $165.75 |
Potential | 8.31% |
Number of Estimates | 23 |
23 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $179.52. This is 8.31% higher than the current stock price. The highest price target is $200.00 20.66% , the lowest is $157.00 5.28% . | |
A rating was issued by 29 analysts: 17 Analysts recommend Procter & Gamble to buy, 11 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 8.31% . Most analysts recommend the Procter & Gamble stock at Purchase. |
21 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $84.8b . This is 0.56% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $86.0b 1.92% , the lowest is $83.6b 0.89% .
This results in the following potential growth metrics:
2024 | $84.0b | 2.48% |
---|---|---|
2025 | $84.8b | 0.93% |
2026 | $87.5b | 3.20% |
2027 | $91.1b | 4.07% |
2028 | $94.4b | 3.62% |
19 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $23.7b . This is 5.12% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $24.3b 7.53% , the lowest is $23.0b 1.99% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $23.1b | 9.60% |
---|---|---|
2025 | $23.7b | 2.76% |
2026 | $25.1b | 5.65% |
2027 | $26.6b | 6.03% |
2028 | $27.5b | 3.56% |
2024 | 27.48% | 6.95% |
---|---|---|
2025 | 27.98% | 1.82% |
2026 | 28.64% | 2.36% |
2027 | 29.18% | 1.89% |
2028 | 29.17% | 0.03% |
11 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $15.7b . This is 6.79% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.4b 11.31% , the lowest is $15.2b 3.03% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.1b | 2.03% |
---|---|---|
2025 | $15.7b | 11.41% |
2026 | $17.1b | 9.00% |
2027 | $18.3b | 6.98% |
2028 | $19.1b | 4.23% |
2024 | 16.80% | 0.43% |
---|---|---|
2025 | 18.54% | 10.38% |
2026 | 19.58% | 5.61% |
2027 | 20.13% | 2.81% |
2028 | 20.25% | 0.60% |
11 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $6.71 . This is 6.85% higher than earnings per share in the financial year 2024. The highest EPS forecast is $6.99 11.31% , the lowest is $6.47 3.03% .
This results in the following potential growth metrics and future valuations:
2024 | $6.02 | 2.03% |
---|---|---|
2025 | $6.71 | 11.46% |
2026 | $7.31 | 8.94% |
2027 | $7.82 | 6.98% |
2028 | $8.15 | 4.22% |
Current | 27.19 | 4.54% |
---|---|---|
2025 | 25.44 | 6.44% |
2026 | 23.34 | 8.25% |
2027 | 21.82 | 6.51% |
2028 | 20.93 | 4.08% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an EV/Sales of 5.02 and an P/S ratio of 4.72 .
This results in the following potential growth metrics and future valuations:
Current | 5.05 | 7.91% |
---|---|---|
2025 | 5.02 | 0.63% |
2026 | 4.86 | 3.10% |
2027 | 4.67 | 3.91% |
2028 | 4.51 | 3.49% |
Current | 4.74 | 8.93% |
---|---|---|
2025 | 4.72 | 0.56% |
2026 | 4.57 | 3.10% |
2027 | 4.39 | 3.91% |
2028 | 4.24 | 3.49% |
Procter & Gamble...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 11 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Apr 03 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 27 2025 |
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Feb 24 2025 |
RBC Capital |
Sector Perform
➜
Sector Perform
|
Unchanged | Jan 23 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jan 23 2025 |
DA Davidson |
Buy
➜
Buy
|
Unchanged | Jan 23 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 11 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Apr 03 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Mar 27 2025 |
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Feb 24 2025 |
Unchanged
RBC Capital:
Sector Perform
➜
Sector Perform
|
Jan 23 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jan 23 2025 |
Unchanged
DA Davidson:
Buy
➜
Buy
|
Jan 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.